A review of Process Analytical Technology (PAT) in the U.S. Pharmaceutical Industry

Current Pharmaceutical Analysis

Volumn 2, Issue 4, 2006, Pages 405-414

  Munson, James ^a   Stanfield, C Freeman ^a   Gujral, Bir ^a  

^a DSM Pharmaceutical Products   (Netherlands)

Author keywords

Analytical; Analyzer; NIR; Process; Technology

Indexed keywords

GENERIC DRUG; NON PRESCRIPTION DRUG;

ANALYTICAL ERROR; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG PACKAGING; DRUG QUALITY; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; MULTIVARIATE ANALYSIS; NEAR INFRARED REFLECTANCE SPECTROSCOPY; NON INVASIVE MEASUREMENT; ONLINE ANALYSIS; PRIORITY JOURNAL; PROCESS MONITORING; REVIEW; STANDARDIZATION; TABLET MANUFACTURE; UNITED STATES;

EID: 33750707888     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341206778699582     Document Type: Review

References (22)

1. Mehta, M. World Pharmaceutical Market, Business Communication Company Inc., 2004.
2. Koch, Mel V. Marquardt J. Impact of Micro-instrumentation on Process Analytical Technology (PAT) A Consortium Approach. PAT, 2004, 1(1), 20-22.
3. Layloff, T. An Overview of Process Analytical Technology in the Pharmaceutical Industry. PAT, 2005, 2(6), 20-22.
4. U.S Department of Health and Human Services FDA Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance. A Final doc., September 2004.
5. Terry, M.; Edward, L. Wright, Introduction to "Analytical Instrumentation: Practical Guides for Measurement and Control", Edited by R. E. Sherman and L. J. Rhodes, Instrument Society of America, 1996.
6. Miller, Jim: FDA Will Drive Big Changes for Contract Business, Outsourcing Outlook, Pharmaceutical Technology, 2003, 110-112.
7. Hussain, A.S. The Subcommittee on Process Analytical Technologies (PAT): Closing Remarks for the FDA's Advisory Committee for Pharmaceutical Science, February 16, 2002, Gaithersburg, MD.
8. Blumenstein, Jeffrey J. Meeting the Regulatory Challenges Associated with Process Analytical Technologies, APR, 2001, 6(4), 69-70.
9. United States Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science Advisory Committee, Process Analytical Technologies Subcommittee, Feb 25-26, 2002.
10. FDA Support Helps Remove Obstacles to Innovation Process Analytical Technology Value Stream Vol.3 NO.1 www.rockwellautomation.com/ valuestream.
11. U.S. Food and Drug Administration, Guidance for Industry. PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, September 2004.
12. Dziki, Walter and Novak Kevin J. Strategies for successful implementation of PAT, APR, Spring 2003, 6(1), 52-61.
13. Bakeev, Katherine A. Process Analytical Technology, Blackwell Publishing, 2005.
14. Simpson, Michael B. Near-Infrared Spectroscopy for Process Analytical Chemistry: Theory, Technology and Implementation; Process analytical technologies. Blackwell Publishing, 2005.
15. Lander, V. Cycle time reduction in manufacturing using a scientific data management system, chimica oggi, Chemistry Today, March/April 2004, 14-16.
16. Manufacturing and Processing, Providing a global perspective on the pharmaceutical industry, World Pharmaceutical Frontiers, 2004, 32-36.
17. Marsaco, Corinne A. Pharma's Process Analytical Technology, C&EN Volume 83, number 8, February 2005, 83(8), 201, 204, 206.
18. Frank, I.; Kowalski, B. Anal. Chem., 1982, 54, 232R-243R.
19. Workman, Jerry Jr. Chemometric and PAT: An Opinion, JJW FDA Chemometric, 2002.
20. http://www.fda.gov/ohrms/dockets/ac/02/briefing/ 3860b2_02_chemometric-WG.ppt (MICROSOFT POWERPOINT).
21. Hussain, Azaz, S. PAT Guidance: Going from Current Negative Vocabulary to Manufacturing Science Enabling Vocabulary. Royal Pharmaceutical Society of London, December 2004.
22. Afinan, Ali, PAT-A framework for innovative Pharmaceutical Development, Manufacturing and Quality Assurance, Royal Pharmaceutical Society of London, December 2004.